Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Author: Avi Kapoor | July 10, 2024 08:01am

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Wednesday.

Shares of Kura Sushi USA, Inc. (NASDAQ:KRUS) fell sharply in today's pre-market trading after the company posted downbeat results for its third quarter on Tuesday.

Kura Sushi reported quarterly earnings of $0.00 per share which missed the analyst consensus estimate of $0.01. The company reported quarterly sales of $63.082 million which missed the analyst consensus estimate of $63.101 million, according to data from Benzinga Pro.

Indivior shares fell 4.2% to $56.00 in the pre-market trading session.

Here are some big stocks recording losses in today's pre-market trading session.

  • LegalZoom.com, Inc. (NASDAQ:LZ) shares dipped 18.3% to $6.41 in pre-market trading after the company announced a CEO transition and lowered its full year guidance.
  • Stardust Power Inc. (NASDAQ:SDST) declined 13.5% to $8.99 in pre-market trading after gaining around 9% on Tuesday.
  • 10x Genomics, Inc. (NASDAQ:TXG) shares fell 9.8% to $16.46 in pre-market trading. On Tuesday, Goldman Sachs analyst Matthew Sykes maintained 10x Genomics with a Sell and lowered the price target from $26 to $16.
  • IDEAYA Biosciences, Inc. (NASDAQ:IDYA) fell 6.4% to $36.13 in pre-market trading. IDEAYA priced $263 million public offering of 228,572 common shares and pre-funded warrants at $35 per share.
  • Hudson Pacific Properties, Inc. (NYSE:HPP) shares declined 4.9% to $4.90 in pre-market trading.
  •  uniQure N.V. (NASDAQ:QURE) slipped 4.5% to $6.37 in pre-market trading. UniQure shares jumped 76% on Tuesday after the company announced updated interim data including up to 24 months of follow-up data from 29 treated patients enrolled in the ongoing U.S. and European Phase I/II clinical trials of AMT-130 for the treatment of Huntington’s disease.
  • Lufax Holding Ltd (NYSE:LU) shares fell 3.7% to $2.86 in pre-market trading after gaining 17% on Tuesday.

Now Read This:

Posted In: HPP IDYA KRUS LU LZ QURE SDST TXG

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist